Merck & Co., Inc. is a major U.S.-based biopharmaceutical company headquartered in New Jersey. It lobbies Congress on drug pricing and Medicare/Medicaid rules (including Medicare Part B and D and the 340B program), animal health and agricultural policy, and tax issues tied to the Internal Revenue Code. Filings show the company reported $16.0 million in lobbying across five filings, most recently on 2026-01-20.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
BRADFORD TALLAMY
The latest disclosures for this client.
MERCK & CO, INC.
Q3MERCK & CO, INC.
Q2The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
These contribution items line up to this client through the same lobbying firm and reporting window, and when available the same contributing lobbyist.
MERCK & CO, INC.
STEPHANIE MCBATH
MERCK & CO, INC.
BRADLEY ALLEN ROSSIN
MERCK & CO, INC.
ELIZABETH SCHWARTZ
MERCK & CO, INC.
ERIN DARLING
MERCK & CO, INC.
ADAM HUFTALEN
MERCK & CO, INC.
THOMAS RADDER
MERCK & CO, INC.
CHARLES CLAPTON
MERCK & CO, INC.
MERCK & CO, INC.
Q1MERCK & CO, INC.
Q4MERCK & CO, INC.
2AMERCK & CO, INC.
Q3MERCK & CO, INC.
Q2MERCK & CO, INC.
Q1